This article summarizes what is known about the dysregulation of the key molecular players involved in SOCE (STIM1, STIM2, Orai1, Orai2, and Orai3) and the negative regulator TRPM4 in prostate cancer. Here, TRPM4 is linked to prostate carcinoma.